Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function.

Receptor tyrosine kinases (RTKs) play a pivotal role in the development and function of the cardiovascular system. Ligand-activated RTKs promote numerous downstream signal transduction pathways that lead to vascular permeability, as well as proliferation, migration, and differentiation of vascular endothelia and smooth muscle cells. Ligand binding also promotes internalization of the activated receptors either to downregulate the signaling via degradation of the ligand/receptor complex or to signal from endosomes. However, the outcomes of receptor internalization via clathrin-dependent or caveolar pathways and trafficking mechanisms are incompletely clarified in vascular systems. Activity modulation through endocytosis and vesicular trafficking significantly impacts downstream targets of RTKs such as endothelial nitric oxide synthase (eNOS) and VE-cadherin. RTKs and their associated targets are also transported to the nucleus, where they may directly impact nuclear signaling. Although the nuclear transport pathways are just beginning to be unraveled, it appears that endocytosis and vesicular trafficking are involved. In this review, we discuss the mechanisms by which activated RTKs and the downstream targets eNOS and VE-cadherin may be internalized and transported to various intracellular compartments. How localization and interacting proteins impact protein function and influence signaling is an important theme, as is the potential for modulating signaling through therapeutic targeting of activated receptors and components of the endocytic machinery. (Circ Res. 2006;98:743-756.)

[1]  M. Foti,et al.  Insulin and IGF-1 receptor trafficking and signalling. , 2008, Novartis Foundation symposium.

[2]  M. Rosen,et al.  Protein-tyrosine Kinase and GTPase Signals Cooperate to Phosphorylate and Activate Wiskott-Aldrich Syndrome Protein (WASP)/Neuronal WASP* , 2006, Journal of Biological Chemistry.

[3]  H. Chan,et al.  Tackling the EGFR in pathological tissue remodelling. , 2006, Pulmonary pharmacology & therapeutics.

[4]  M. Marletta,et al.  Subcellular Targeting and Differential S-Nitrosylation of Endothelial Nitric-oxide Synthase* , 2006, Journal of Biological Chemistry.

[5]  B. van Deurs,et al.  Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way , 2006, Journal of Cell Science.

[6]  G. Giaccone,et al.  Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies , 2005, International journal of cancer.

[7]  L. E. Johannessen,et al.  The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane. , 2005, Molecular biology of the cell.

[8]  R. Cordera,et al.  Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism. , 2005, Biochemical and biophysical research communications.

[9]  M. Komada,et al.  Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes. , 2005, Molecular biology of the cell.

[10]  K. Schilling,et al.  NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS , 2005, Journal of Cell Science.

[11]  E. Dejana,et al.  p120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin. , 2005, Molecular biology of the cell.

[12]  D. Mukhopadhyay,et al.  Regulatory role of dynamin‐2 in VEGFR‐2/KDR‐mediated endothelial signaling , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  W. Sessa,et al.  Intracellular location regulates calcium-calmodulin-dependent activation of organelle-restricted eNOS. , 2005, American journal of physiology. Cell physiology.

[14]  J. Stow,et al.  Nuclear Translocation of Cell‐Surface Receptors: Lessons from Fibroblast Growth Factor , 2005, Traffic.

[15]  Charles C. Reed,et al.  Decorin Evokes Protracted Internalization and Degradation of the Epidermal Growth Factor Receptor via Caveolar Endocytosis* , 2005, Journal of Biological Chemistry.

[16]  D. Cheresh,et al.  Tyrosine Phosphorylation of VE-cadherin Prevents Binding of p120- and β-Catenin and Maintains the Cellular Mesenchymal State* , 2005, Journal of Biological Chemistry.

[17]  D. Predescu,et al.  Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[18]  M. Schleicher,et al.  Cell Cycle-Regulated Inactivation of Endothelial NO Synthase through NOSIP-Dependent Targeting to the Cytoskeleton , 2005, Molecular and Cellular Biology.

[19]  L. Pelkmans,et al.  Assembly and trafficking of caveolar domains in the cell , 2005, The Journal of cell biology.

[20]  L. Gunaratnam,et al.  Regulation of ubiquitin ligase dynamics by the nucleolus , 2005, The Journal of cell biology.

[21]  T. Sommer,et al.  ERAD: the long road to destruction , 2005, Nature Cell Biology.

[22]  K. Rottner,et al.  N-WASP deficiency impairs EGF internalization and actin assembly at clathrin-coated pits , 2005, Journal of Cell Science.

[23]  Lucas Pelkmans,et al.  Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae , 2005, Nature.

[24]  Bianca Habermann,et al.  Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis , 2005, Nature.

[25]  S. Eguchi,et al.  The role of reactive oxygen species in insulin signaling in the vasculature. , 2005, Antioxidants & redox signaling.

[26]  I. Dikic,et al.  Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation , 2005, EMBO reports.

[27]  T. Kirchhausen,et al.  The Small G-protein Arf6GTP Recruits the AP-2 Adaptor Complex to Membranes* , 2005, Journal of Biological Chemistry.

[28]  C. Tacchetti,et al.  Relationships between EGFR signaling-competent and endocytosis-competent membrane microdomains. , 2005, Molecular biology of the cell.

[29]  A. Gressner,et al.  Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells , 2005, Growth factors.

[30]  L. Elferink,et al.  The Listeria Protein Internalin B Mimics Hepatocyte Growth Factor‐Induced Receptor Trafficking , 2005, Traffic.

[31]  K. Siddle,et al.  Grb10 and Grb14: enigmatic regulators of insulin action--and more? , 2005, The Biochemical journal.

[32]  Richard G. W. Anderson,et al.  Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Controls Endocytosis and c-CBL-mediated Ubiquitination of the Platelet-derived Growth Factor Receptor β (PDGFRβ)* , 2005, Journal of Biological Chemistry.

[33]  M. McNiven,et al.  Caveolin-1 interacts directly with dynamin-2. , 2005, Journal of molecular biology.

[34]  P. Dell’Era,et al.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. , 2005, Cytokine & growth factor reviews.

[35]  N. Rahimi,et al.  The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation. , 2005, Molecular biology of the cell.

[36]  M. Sirois,et al.  Vascular Endothelial Growth Factor (VEGF)-A165-induced Prostacyclin Synthesis Requires the Activation of VEGF Receptor-1 and -2 Heterodimer* , 2005, Journal of Biological Chemistry.

[37]  R. Alexander,et al.  Novel Role of ARF6 in Vascular Endothelial Growth Factor–Induced Signaling and Angiogenesis , 2005, Circulation research.

[38]  A. Sorkin,et al.  Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. , 2005, Molecular biology of the cell.

[39]  W. Sessa Regulation of endothelial derived nitric oxide in health and disease. , 2005, Memorias do Instituto Oswaldo Cruz.

[40]  P. Transidico,et al.  Clathrin-independent endocytosis of ubiquitinated cargos. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Christé,et al.  Vascular Endothelial–Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult Tissues , 2005, Circulation research.

[42]  I. Dikic,et al.  Src Phosphorylation of Alix/AIP1 Modulates Its Interaction with Binding Partners and Antagonizes Its Activities* , 2005, Journal of Biological Chemistry.

[43]  Jeffrey L. Wrana,et al.  Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling , 2005, Nature Reviews Molecular Cell Biology.

[44]  W. Sessa,et al.  Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  W. Sessa,et al.  Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Borst,et al.  Ubiquitin Ligase Activity of c-Cbl Guides the Epidermal Growth Factor Receptor into Clathrin-coated Pits by Two Distinct Modes of Eps15 Recruitment* , 2004, Journal of Biological Chemistry.

[47]  M. Parat,et al.  A role for caveolae in cell migration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  P. Maher,et al.  Ligand dependent and independent internalization and nuclear translocation of fibroblast growth factor (FGF) receptor 1. , 2004, DNA and cell biology.

[49]  F. Wylie,et al.  Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin. , 2004, Molecular biology of the cell.

[50]  A. Kazlauskas,et al.  VE-cadherin increases the half-life of VEGF receptor 2. , 2004, Experimental cell research.

[51]  R. Bowler,et al.  Colocalization of eNOS and the Catalytic Subunit of PKA in Endothelial Cell Junctions: A Clue for Regulated NO Production , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[52]  W. Cavenee,et al.  Alix/AIP1 Antagonizes Epidermal Growth Factor Receptor Downregulation by the Cbl-SETA/CIN85 Complex , 2004, Molecular and Cellular Biology.

[53]  L. Pelkmans,et al.  Caveolin-Stabilized Membrane Domains as Multifunctional Transport and Sorting Devices in Endocytic Membrane Traffic , 2004, Cell.

[54]  T. Murohara,et al.  Nitric oxide signaling during myocardial angiogenesis , 2004, Molecular and Cellular Biochemistry.

[55]  I. Amit,et al.  LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation , 2004, The EMBO journal.

[56]  J. McCullough,et al.  AMSH is an endosome-associated ubiquitin isopeptidase , 2004, The Journal of cell biology.

[57]  E. Raines PDGF and cardiovascular disease. , 2004, Cytokine & growth factor reviews.

[58]  J. Stow,et al.  The ins and outs of E-cadherin trafficking. , 2004, Trends in cell biology.

[59]  Sebastian Maurer-Stroh,et al.  Crystal structure of the p14/MP1 scaffolding complex: how a twin couple attaches mitogen-activated protein kinase signaling to late endosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  W. Sessa,et al.  Targeting of Endothelial Nitric-oxide Synthase to the Cytoplasmic Face of the Golgi Complex or Plasma Membrane Regulates Akt- Versus Calcium-dependent Mechanisms for Nitric Oxide Release* , 2004, Journal of Biological Chemistry.

[61]  T. Langer,et al.  Membrane protein turnover by the m‐AAA protease in mitochondria depends on the transmembrane domains of its subunits , 2004, EMBO reports.

[62]  Elisabetta Dejana,et al.  Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. , 2004, Physiological reviews.

[63]  E. Van Obberghen,et al.  Grb10 Prevents Nedd4-mediated Vascular Endothelial Growth Factor Receptor-2 Degradation* , 2004, Journal of Biological Chemistry.

[64]  W. Sessa,et al.  Caveolae and Caveolins in the Cardiovascular System , 2004, Circulation research.

[65]  P. Vincent,et al.  VE-cadherin: adhesion at arm's length. , 2004, American journal of physiology. Cell physiology.

[66]  M. Shibuya,et al.  The c‐Cbl/CD2AP complex regulates VEGF‐induced endocytosis and degradation of Flt‐1 (VEGFR‐1) , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  Douglas R Lowy,et al.  E‐cadherin‐mediated adhesion inhibits ligand‐dependent activation of diverse receptor tyrosine kinases , 2004, The EMBO journal.

[68]  H. Ploegh,et al.  Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin. , 2004, Molecular biology of the cell.

[69]  N. Himes,et al.  Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. , 2004, The Journal of clinical investigation.

[70]  P. Delafontaine,et al.  Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[71]  Zhixiang Wang,et al.  Platelet-derived Growth Factor Receptor-mediated Signal Transduction from Endosomes* , 2004, Journal of Biological Chemistry.

[72]  Bianca Habermann,et al.  APPL Proteins Link Rab5 to Nuclear Signal Transduction via an Endosomal Compartment , 2004, Cell.

[73]  Gerhard Christofori,et al.  Cell adhesion and signalling by cadherins and Ig-CAMs in cancer , 2004, Nature Reviews Cancer.

[74]  W. Sessa,et al.  Chaperone-dependent Regulation of Endothelial Nitric-oxide Synthase Intracellular Trafficking by the Co-chaperone/Ubiquitin Ligase CHIP* , 2003, Journal of Biological Chemistry.

[75]  Richard G. W. Anderson,et al.  Caveolin regulation of endothelial function. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[76]  M. J. Clague,et al.  Hrs function: viruses provide the clue. , 2003, Trends in cell biology.

[77]  A. Wandinger-Ness,et al.  Rab proteins and endocytic trafficking: potential targets for therapeutic intervention. , 2003, Advanced drug delivery reviews.

[78]  I. Dikic,et al.  Dab2 links CIN85 with clathrin‐mediated receptor internalization , 2003, FEBS letters.

[79]  M. Yen,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. , 2003, Molecular pharmacology.

[80]  R. Jain,et al.  Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis , 2003, Circulation research.

[81]  J. Donaldson Multiple Roles for Arf6: Sorting, Structuring, and Signaling at the Plasma Membrane* , 2003, Journal of Biological Chemistry.

[82]  L. Frati,et al.  Ligand‐induced clathrin‐mediated endocytosis of the keratinocyte growth factor receptor occurs independently of either phosphorylation or recruitment of eps15 , 2003, FEBS letters.

[83]  V. Shah,et al.  Inhibition of GTP-dependent vesicle trafficking impairs internalization of plasmalemmal eNOS and cellular nitric oxide production , 2003, Journal of Cell Science.

[84]  P. Cirri,et al.  Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. , 2003, Trends in biochemical sciences.

[85]  J. Gratton,et al.  Vascular Endothelial Growth Factor-dependent Down-regulation of Flk-1/KDR Involves Cbl-mediated Ubiquitination , 2003, Journal of Biological Chemistry.

[86]  M. Corada,et al.  Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148 , 2003, The Journal of cell biology.

[87]  A. Vecchione,et al.  The Grb10/Nedd4 Complex Regulates Ligand-Induced Ubiquitination and Stability of the Insulin-Like Growth Factor I Receptor , 2003, Molecular and Cellular Biology.

[88]  Pier Paolo Di Fiore,et al.  Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation , 2003, Nature Cell Biology.

[89]  Ivan Dikic,et al.  Negative receptor signalling. , 2003, Current opinion in cell biology.

[90]  P. Monzo,et al.  CD2AP/CMS Regulates Endosome Morphology and Traffic to the Degradative Pathway Through its Interaction with Rab4 and c‐Cbl , 2003, Traffic.

[91]  A. Santiago-Walker,et al.  Endocytosis of Epidermal Growth Factor Receptor Regulated by Grb2-mediated Recruitment of the Rab5 GTPase-activating Protein RN-tre* , 2002, The Journal of Biological Chemistry.

[92]  J. Baleja,et al.  Rab11-FIP2, an Adaptor Protein Connecting Cellular Components Involved in Internalization and Recycling of Epidermal Growth Factor Receptors* , 2002, The Journal of Biological Chemistry.

[93]  N. Opitz,et al.  NOSTRIN: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[94]  David S. Park,et al.  Glomerular endothelial fenestrae in vivo are not formed from caveolae. , 2002, Journal of the American Society of Nephrology : JASN.

[95]  Y. Yarden,et al.  Ligand‐Independent Degradation of Epidermal Growth Factor Receptor Involves Receptor Ubiquitylation and Hgs, an Adaptor Whose Ubiquitin‐Interacting Motif Targets Ubiquitylation by Nedd4 , 2002, Traffic.

[96]  A. Wells,et al.  Signalling shortcuts: cell-surface receptors in the nucleus? , 2002, Nature Reviews Molecular Cell Biology.

[97]  Elisabetta Dejana,et al.  VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[98]  Robert S Warren,et al.  Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[99]  D. Fremont,et al.  Accessory protein recruitment motifs in clathrin-mediated endocytosis. , 2002, Structure.

[100]  E. V. van Donselaar,et al.  Endothelial Nitric Oxide Synthase and Its Negative Regulator Caveolin-1 Localize to Distinct Perinuclear Organelles , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[101]  Pier Paolo Di Fiore,et al.  A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins , 2002, Nature.

[102]  I. Dikic,et al.  Cbl–CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors , 2002, Nature.

[103]  L. Maulon,et al.  Rapid Transactivation of the Vascular Endothelial Growth Factor Receptor KDR/Flk-1 by the Bradykinin B2 Receptor Contributes to Endothelial Nitric-oxide Synthase Activation in Cardiac Capillary Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[104]  M. Goldfarb Signaling By Fibroblast Growth Factors: The Inside Story , 2001, Science's STKE.

[105]  T. Martin PI(4,5)P(2) regulation of surface membrane traffic. , 2001, Current opinion in cell biology.

[106]  P. Camilli,et al.  Endocytosis and Signaling An Inseparable Partnership , 2001, Cell.

[107]  W. Sessa,et al.  Direct Interaction between Endothelial Nitric-oxide Synthase and Dynamin-2 , 2001, The Journal of Biological Chemistry.

[108]  G. Christofori,et al.  Mammalian Sprouty-1 and -2 Are Membrane-Anchored Phosphoprotein Inhibitors of Growth Factor Signaling in Endothelial Cells , 2001, The Journal of cell biology.

[109]  H. Steven Wiley,et al.  Regulation of Receptor Tyrosine Kinase Signaling by Endocytic Trafficking , 2001, Traffic.

[110]  W. Kummer,et al.  NOSIP, a novel modulator of endothelial nitric oxide synthase activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  P. Verkade,et al.  Apical Membrane Targeting of Nedd4 Is Mediated by an Association of Its C2 Domain with Annexin Xiiib , 2000, The Journal of cell biology.

[112]  D. Donner,et al.  Homeostatic Modulation of Cell Surface KDR and Flt1 Expression and Expression of the Vascular Endothelial Cell Growth Factor (VEGF) Receptor mRNAs by VEGF* , 2000, The Journal of Biological Chemistry.

[113]  S. Schmid,et al.  Regulation of signal transduction by endocytosis. , 2000, Current opinion in cell biology.

[114]  P E Thorpe,et al.  Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[115]  C. Larabell,et al.  Actin-Dependent Propulsion of Endosomes and Lysosomes by Recruitment of N-Wasp✪ , 2000, The Journal of cell biology.

[116]  D. Bowtell,et al.  The Cbl protooncoprotein stimulates CSF‐1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation , 1999, The EMBO journal.

[117]  S. Steinberg,et al.  Activated protein kinase C isoforms target to cardiomyocyte caveolae : stimulation of local protein phosphorylation. , 1999, Circulation research.

[118]  V. J. Venema,et al.  VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. , 1999, Biochemical and biophysical research communications.

[119]  D. Golan,et al.  Receptor-regulated Translocation of Endothelial Nitric-oxide Synthase* , 1998, The Journal of Biological Chemistry.

[120]  P. Oh,et al.  Dynamin at the Neck of Caveolae Mediates Their Budding to Form Transport Vesicles by GTP-driven Fission from the Plasma Membrane of Endothelium , 1998, The Journal of cell biology.

[121]  G. Condorelli,et al.  Insulin-like Growth Factor-I Receptor Internalization Regulates Signaling via the Shc/Mitogen-activated Protein Kinase Pathway, but Not the Insulin Receptor Substrate-1 Pathway* , 1998, The Journal of Biological Chemistry.

[122]  K. Miura,et al.  N‐WASP, a novel actin‐depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2‐dependent manner downstream of tyrosine kinases. , 1996, The EMBO journal.

[123]  M. Lisanti,et al.  Phosphorylation of Caveolin by Src Tyrosine Kinases , 1996, The Journal of Biological Chemistry.

[124]  P. Oh,et al.  Endothelial Caveolae Have the Molecular Transport Machinery for Vesicle Budding, Docking, and Fusion Including VAMP, NSF, SNAP, Annexins, and GTPases (*) , 1995, The Journal of Biological Chemistry.

[125]  T. Shirasawa,et al.  Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. , 1995, Biochemical and biophysical research communications.

[126]  L. Cantley,et al.  Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3' kinase complexes: potential interactions with the microtubule cytoskeleton , 1993, Molecular and cellular biology.

[127]  N. Copeland,et al.  A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[128]  M. Shibuya,et al.  Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.

[129]  R. Copeland,et al.  Quantitative assays of Mdm2 ubiquitin ligase activity and other ubiquitin-utilizing enzymes for inhibitor discovery. , 2005, Methods in enzymology.

[130]  A. Wandinger-Ness,et al.  The proteasome alpha-subunit XAPC7 interacts specifically with Rab7 and late endosomes. , 2004, The Journal of biological chemistry.

[131]  P. Stahl,et al.  Role of rab5 in EGF receptor-mediated signal transduction. , 2004, European journal of cell biology.

[132]  K. Stoletov,et al.  VEGF treatment induces signaling pathways that regulate both actin polymerization and depolymerization , 2004, Angiogenesis.

[133]  H. Riedel Grb10 exceeding the boundaries of a common signaling adapter. , 2004, Frontiers in bioscience : a journal and virtual library.

[134]  J. Wrana,et al.  Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. , 2003, Nature cell biology.

[135]  D. Gingras,et al.  Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. , 2003, Molecular biology of the cell.

[136]  N. Naslavsky,et al.  Involves Arf6 Inactivation and Changes in Phosphoinositides , 2002 .

[137]  Ulf Eriksson,et al.  Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[138]  Z. Yang,et al.  Phorbol ester downregulates PDGFbeta receptor via PKCbeta1 in vascular smooth muscle cells. , 2001, Biochemical and biophysical research communications.

[139]  B. Honig,et al.  To B or not to B: PIP2 answers the question. , 2005, Developmental Cell.